Dual antiplatelet treatment associated with reduced risk of symptomatic vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage
Gyeong-Ung Sun, Eunsung Park, Dae-Won Kim, Sung-Don Kang
J Cerebrovasc Endovasc Neurosurg. 2020;22(3):134-140.   Published online 2020 Sep 21     DOI: https://doi.org/10.7461/jcen.2020.22.3.134
Citations to this article as recorded by Crossref logo
Applied forecasting for delayed cerebral ischemia prediction post subarachnoid hemorrhage: Methodological fallacies
Georgios Alexopoulos, Justin Zhang, Ioannis Karampelas, Maheen Khan, Nabiha Quadri, Mayur Patel, Niel Patel, Mohammad Almajali, Tobias A. Mattei, Joanna Kemp, Jeroen Coppens, Philippe Mercier
Informatics in Medicine Unlocked.2022; 28: 100817.     CrossRef
Platelet count is not associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as defined by the 2010 consensus definition
Essi Raatikainen, Heikki Kiiski, Anne Kuitunen, Eija Junttila, Heini Huhtala, Antti Ronkainen, Liisa Pyysalo, Annukka Vahtera
Journal of the Neurological Sciences.2022; 436: 120227.     CrossRef
Analysis of the Reactivity of Aspirin and Clopidogrel and Its Influencing Factors in Patients with Coronary Heart Disease at High Altitude
Rong Chang, Jinchun Wu, Xiaofei Zhang, Yi Ye, Wenqin Zhou, Yanmin Liu, Songwen Tan
Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
Vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage
Masaaki Sakuraya
Journal of the Japanese Society of Intensive Care Medicine.2021; 28(6): 509.     CrossRef